Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564051 · ClinicalTrials.gov registry record
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 29
- Enrollment target
NCT06564051: Clinical Trial study, sponsored by Mayo Clinic.
NCT06564051 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564051 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study evaluates the incidence of monoclonal B-cell lymphocytosis MBL) in patients with chronic hepatitis C and to determine if monoclonal b-cell lymphocytosis is affected by treatment for hepatitis C.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2025-12-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06564051
The ClinicalTrials.gov registry entry for NCT06564051 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06564051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06564051 about?
NCT06564051 is a clinical study titled "Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C". This study evaluates the incidence of monoclonal B-cell lymphocytosis MBL) in patients with chronic hepatitis C and to determine if monoclonal b-cell lymphocytosis is affected by treatment for hepatitis C.
What is the current status of trial NCT06564051?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2017-11-14. Estimated completion is 2025-12-03.
What interventions are being tested in trial NCT06564051?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06564051?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.